Independent Domestication Of A Tailed Bacteriop...

Factors Associated With The Delay In Seeking Le...

Bone Marrow-derived Mononuclear Stem Cell Impla...

Body Mass Index And Height Growth Curves Are In...

Efficacy Of Antibacterial Prophylaxis For Preve...

0 votes
Plasmatic Neurosin As A New Potential Biomarker In The Differential Diagnosis Of Patients With Cognitive Impairment
Author: Manuel Menéndez González , Marta Martínez Rivera, Alfonso López-muñiz
Publisher: Internet Medical Publishing
3 pages
One time payment: €6.08
Required subscription: Clinical
Type of publication: Article
DOI: 10:3823/056
Follow this publisher

Share this publication:


Measuring plasmatic neurosin and other biomarkers early in the course of cognitive impairment could open the door to more effective interventions. Further tests are needed before this approach can be used in clinical practice.

About the publisher:

iMedPub Limited is a publishing house registered in UK, publishing medical books and journals since 2005. As an open service to doctors and biomedical researchers, it is driven by clinicians and researchers for themselves, while serving the interests of the general public. iMedPub disseminates research in a tiered system, beginning with our specialty books and journals and then working upwards. The grand vision of iMedPub is a world where all medical researchers and health professionals have an equal opportunity to seek, share and create knowledge. As we are a low cost academic publisher we offer the lowest article processing charges of all biomedical journals and publish books free of charges for authors.

Select a payment method